Valion Bio outlines three-part strategy under new interim CEO Oct 21, 2026 08:02AM
Valion Bio's New Leadership Unveils 30-Day Agenda to Accelerate Clinical Pipeline and Unlock Shareholder Value Oct 21, 2026 08:00AM
Valion Bio unit completes early NMR feasibility test with LarmorBio Oct 15, 2026 08:06AM
Valion Bio's Next-Generation NMR Partnership with LarmorBio Delivers Initial Feasibility Milestone Oct 15, 2026 08:00AM
With Section 232 Tariffs Reshaping Biotech, Valion Bio's Velocity Bioworks Capitalizes on Domestic CDMO Surge Oct 14, 2026 08:15AM


Oct 9, 2026 07:51AM Valion Bio develops oral form of radiation countermeasure Entolimod
Oct 9, 2026 07:45AM Valion Bio (Nasdaq:VBIO): Oral Mucosal Entolimod Could Offer a New Needle-Free Deployment Path to Support Growing Need for Scalable Civilian Radiation Preparedness Should Nuclear Infrastructure Expand
Oct 8, 2026 06:07AM Vitality Biopharma Inc. (VBIO) files $100M mixed shelf
Oct 5, 2026 08:30AM New Valion Bio Board Chair Thomas Jensen Brings Biotech Turnaround Experience to the Advancement of Entolimod
Sep 23, 2026 08:01AM Valion Bio names board member Dean Zikria as interim CEO
Sep 23, 2026 08:00AM Valion Appoints Life Sciences Veteran Dean Zikria as Interim CEO and Announces Board Leadership Transitions
Sep 22, 2026 08:01AM Valion Bio regains Nasdaq minimum bid price compliance
Sep 22, 2026 08:00AM Valion Bio Regains Compliance with NASDAQ Minimum Bid Price Listing Rule
Sep 1, 2026 08:01AM Valion Bio names CFO Lisa Wolf as president and COO after CEO exits
Sep 1, 2026 08:00AM Valion Bio Announces Changes to Management and Board of Directors
Aug 27, 2026 08:31AM Valion Bio sets 1-for-25 reverse split to meet Nasdaq rules
Aug 27, 2026 08:30AM Valion Bio Announces Reverse Stock Split
Aug 13, 2026 10:00AM Ukraine's Ministry Of Health Advances Entolimod Review Into Technical Assessment Phase
Aug 12, 2026 09:32AM AFRRI begins government-funded Entolimod radiation injury study
Aug 12, 2026 09:29AM Valion Bio Announces U.S. Government-Funded Entolimod Studies Targeting Lethal Radiation-Induced GI Injury
Jul 20, 2026 01:30PM Sheba Medical Center to trial Valion Bio's Entolimod in cancer patients
Jul 14, 2026 07:45AM Valion Bio reports manufacturing scale-up and government talks for Entolimod
Jun 25, 2026 07:45AM AFRRI and NIAID complete protocol to test Valion Bio's Entolimod
Jun 11, 2026 07:45AM Valion Bio notes House committee directive on radiation countermeasures
May 14, 2026 04:32PM Velocity Bioworks secures exclusive license for BioScan-NMR platform
May 5, 2026 08:02AM Valion Bio receives $7 million NIAID funding for radiation syndrome drug
Apr 23, 2026 04:06PM Tivic Health rebrands to Valion Bio, changes ticker to VBIO